콘텐츠로 건너뛰기
Merck
  • Efficiency of lyticase (bacterial enzyme) in experimental candidal vaginitis in mice.

Efficiency of lyticase (bacterial enzyme) in experimental candidal vaginitis in mice.

Bulletin of experimental biology and medicine (2010-12-18)
N P Sachivkina, E G Kravtsov, E A Wasileva, I V Anokchina, M V Dalin
초록

Lyticase (a bacterial enzyme) was tested as a new antimycotic drug. Of all objects studied, Cellulomonas cellulans AC-870 strain proved to be most productive for this enzyme. A technology for lyticase isolation and purification was proposed. An experimental model of recurrent vaginal candidiasis was created. The model includes combined antibiotic and estradiol therapy. Antimycotic effect of lyticase on the model of recurrent vaginal candidiasis in mice was demonstrated.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
β-(1→3)-D-Glucanase from Helix pomatia, ≥0.2 U/mg